TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30018175

Group type: EXPERIMENTAL
Intervention: Mechanical Insufflation-Exsufflation (MI-E) during respiratory physiotherapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard respiratory physiotherapy alone (Control)
Number of subjects: 90
Study: 27085586

Group type: EXPERIMENTAL
Intervention: PF‐06260414 (1 to 400 mg for SAD, 3 to 100 mg BID for MAD, 60 mg once-daily, 30 mg BID for Japanese cohort)
Number of subjects: 31

Group type: COMPARATOR
Intervention: PF‐06260414 (100 mg BID)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: PF‐06260414
Number of subjects: 31
Study: 24185642

Group type: EXPERIMENTAL
Intervention: Face-to-face information combined with a booklet (Back Book)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Booklet alone
Number of subjects: 181
Study: 22584452

Group type: EXPERIMENTAL
Intervention: Magnetostrictive ultrasonic instruments
Number of subjects: 18

Group type: COMPARATOR
Intervention: Piezoelectric ultrasonic instruments
Number of subjects: 18
Study: 20335313

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 18612863

Group type: EXPERIMENTAL
Intervention: Clinician-assisted computerized cognitive behavioural treatment programme
Number of subjects: 88

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 88
Study: 16038711

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (APT)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OAC)
Number of subjects: 427

Group type: COMPARATOR
Intervention: No antiplatelet therapy (control group)
Number of subjects: 427

Group type: COMPARATOR
Intervention: No oral anticoagulants (control group)
Number of subjects: 427
Study: 12394349

Group type: EXPERIMENTAL
Intervention: Individual genetic risk counseling
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Group psychosocial counseling
Number of subjects: 357

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 357
Study: 10530833

Group type: EXPERIMENTAL
Intervention: Knees with ACL loss
Number of subjects: 35

Group type: COMPARATOR
Intervention: Undamaged knees of patients
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group knees
Number of subjects: 35
Study: 7621766

Group type: EXPERIMENTAL
Intervention: Brief infrared laser heat pulses applied to the right temple
Number of subjects: 10
Study: 2025015

Group type: EXPERIMENTAL
Intervention: MMR II
Number of subjects: 77

Group type: COMPARATOR
Intervention: Pluserix
Number of subjects: 77
Study: 7249316

Group type: EXPERIMENTAL
Intervention: New procedure (minimal right ventriculotomy and pulmonary valve repair)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional procedure (right ventriculotomy without pulmonary valve repair)
Number of subjects: 42
Study: 31244487

Group type: EXPERIMENTAL
Intervention: TheraSling therapy (TST) combined with neuromuscular facilitation technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Neuromuscular facilitation technique (Control)
Number of subjects: 56
Study: 28361235

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 103

Group type: COMPARATOR
Intervention: Typical American diet (control)
Number of subjects: 103
Study: 25072405

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy administered over the telephone (CBT-T)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy administered in-person (CBT-IP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 100
Study: 23910207

Group type: EXPERIMENTAL
Intervention: Self-ligating brackets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional brackets ligated with stainless steel ligatures
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (self-ligating and conventional brackets)
Number of subjects: 20
Study: 21764705

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pre‐anesthetic volume with Voluven
Number of subjects: 40
Study: 18435723

Group type: EXPERIMENTAL
Intervention: Trident White (TW) gum
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Orbit gum
Number of subjects: 10
Study: 16499515

Group type: EXPERIMENTAL
Intervention: Buprenorphine depot injection (58 mg)
Number of subjects: 11
Study: 12910861

Group type: EXPERIMENTAL
Intervention: Foot-pump (A-V Impulse System)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Low molecular weight heparin (Fraxiparin)
Number of subjects: 106
Study: 10884451

Group type: EXPERIMENTAL
Intervention: rTPA (0.9 mg/kg IV)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 9333327

Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (1-3 μg x kg-1 x min-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine administration of low-dose dopamine
Number of subjects: 0
Study: 8480823

Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral treatment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Drug abuse counseling
Number of subjects: 38
Study: 3425252

Group type: EXPERIMENTAL
Intervention: Cervical scoring in accordance with Westin performed in weeks 24, 28 and 32 for groups I, II, and III
Number of subjects: 1327

Group type: EXPERIMENTAL
Intervention: Cervical scoring in accordance with Westin
Number of subjects: 1327

Group type: COMPARATOR
Intervention: Cervical examination in low-risk pregnancies
Number of subjects: 1327
Study: 29983095

Group type: EXPERIMENTAL
Intervention: Microwave ablation during liver resection (group B, n = 39)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Liver resection without microwave ablation (group A, n = 40)
Number of subjects: 79
Study: 28334979

Group type: EXPERIMENTAL
Intervention: Clinical medication reviews (CMR)
Number of subjects: 518

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 518
Study: 25440820

Group type: EXPERIMENTAL
Intervention: Supine position (transgluteal)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 98
Study: 23480528

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study: 21181138

Group type: EXPERIMENTAL
Intervention: Genotype GG of rs4532
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Haplotype CGC of rs5326-rs4532-rs265975
Number of subjects: 382
Study: 18584240

Group type: EXPERIMENTAL
Intervention: Low-dose TACE (2 mg mitomycin C, 10 mg epirubicin, 100 mg carboplatin)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High-dose TACE (10 mg mitomycin C, 40 mg epirubicin, 300 mg carboplatin)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no TACE)
Number of subjects: 54
Study: 17070365

Group type: EXPERIMENTAL
Intervention: 5 mg tadalafil
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: 10 mg tadalafil
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: 20 mg tadalafil
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 14560892

Group type: EXPERIMENTAL
Intervention: Surgical treatment for early-stage endometriosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatment for moderate and severe endometriosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical treatment inducing an anovulatory state
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assisted reproductive technologies (ART) including IVF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endometriomas impact on IVF outcome
Number of subjects: 0
Study: 10964269

Group type: EXPERIMENTAL
Intervention: Indoor residual spraying with alphacypermethrin (Fendona) at 25 mg/m2
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Indoor residual spraying with suspension concentrate (SC) formulation
Number of subjects: 180

Group type: COMPARATOR
Intervention: Unsprayed control
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Monitoring of Anopheles culicifacies and A.stephensi populations
Number of subjects: 180
Study: 8829929

Group type: EXPERIMENTAL
Intervention: Topical administration of 1 mg kg‐1 lignocaine 2% to the medial part of the eye after induction of anaesthesia (Group II)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Topical administration of lignocaine after a 5 min interval (Group III)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Stimulation of the reflex without lignocaine (Group I)
Number of subjects: 56
Study: 1392493

Group type: EXPERIMENTAL
Intervention: Rose Shu‐Xin oral liquid
Number of subjects: 200

Group type: COMPARATOR
Intervention: Salvia miltiorrhiza tablet
Number of subjects: 200
Study: 2414590

Group type: EXPERIMENTAL
Intervention: Verapamil 160 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil or Nisoldipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (general)
Number of subjects: 0
Study: 31093980

Group type: EXPERIMENTAL
Intervention: hATTR amyloidosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Type 2 diabetes
Number of subjects: 0

Group type: COMPARATOR
Intervention: General population
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronic diseases
Number of subjects: 0
Study: 28229570

Group type: EXPERIMENTAL
Intervention: Traditional linear periodized resistance training program (EX group, N=10)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No resistance training (C group, N=8)
Number of subjects: 18
Study: 27346728

Group type: EXPERIMENTAL
Intervention: Brivaracetam 10 mg tablet
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Brivaracetam 75 mg tablet
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Brivaracetam 100 mg tablet
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Brivaracetam 100 mg intravenous bolus
Number of subjects: 25

Group type: COMPARATOR
Intervention: Brivaracetam 50 mg tablet
Number of subjects: 25
Study: 25891548

Group type: EXPERIMENTAL
Intervention: Low-dose PDA-001 (150×10(6) cells)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-dose PDA-001 (600×10(6) cells)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 22198469

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 20727735

Group type: EXPERIMENTAL
Intervention: ECC+P (Epirubicin, Cisplatin, Capecitabine + Pravastatin 40 mg once daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: ECC (Epirubicin, Cisplatin, Capecitabine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: ECC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ECC+P
Number of subjects: 30
Study: 18830672

Group type: EXPERIMENTAL
Intervention: Stress-coping model
Number of subjects: 121
Study: 16036099

Group type: EXPERIMENTAL
Intervention: Strontium ranelate 2 g daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12075212

Group type: EXPERIMENTAL
Intervention: 1-appointment group (n = 39)
Number of subjects: 72

Group type: COMPARATOR
Intervention: 2-appointment group (n = 33)
Number of subjects: 72
Study: 10353498

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Low-force mimic (LFM) maneuver
Number of subjects: 138
Study: 7497761

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 12
Study: 8461542

Group type: EXPERIMENTAL
Intervention: Calcium plus calcitriol
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Calcium plus calcitriol and nasal salmon calcitonin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Calcium supplementation alone
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Calcitriol alone
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Calcitriol with nasal calcitonin
Number of subjects: 103
Study: 2945717

Group type: EXPERIMENTAL
Intervention: Sufentanil 30 micrograms
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sufentanil 50 micrograms
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sufentanil 75 micrograms
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no sufentanil)
Number of subjects: 30
Study: 31734798

Group type: EXPERIMENTAL
Intervention: Medication Management Service (MMS)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 129
Study: 30146136

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Experimental reading task
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 106
Study: 26394882

Group type: EXPERIMENTAL
Intervention: tiotropium (18 μg once daily) + budesonide/formoterol (160/4.5 μg 2 inhalations twice daily)
Number of subjects: 578

Group type: COMPARATOR
Intervention: tiotropium alone (18 μg once daily)
Number of subjects: 578
Study: 23954497

Group type: EXPERIMENTAL
Intervention: DM-Training (24 nurse-coached exercise sessions)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: DM-Exposure (4 exercise sessions)
Number of subjects: 3

Group type: COMPARATOR
Intervention: DM (home-walking program)
Number of subjects: 3
Study: 22521199

Group type: EXPERIMENTAL
Intervention: Push method
Number of subjects: 59

Group type: COMPARATOR
Intervention: Pull method
Number of subjects: 59
Study: 20816149

Group type: EXPERIMENTAL
Intervention: Cerclage
Number of subjects: 301

Group type: COMPARATOR
Intervention: No cerclage
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: U-shaped funnel
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: V-shaped funnel
Number of subjects: 301
Study: 18485132

Group type: EXPERIMENTAL
Intervention: Torasemide prolonged release (PR) 5 mg/day (uptitration to 10 mg/day if no response at 4 or 8 weeks)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Torasemide immediate release (IR) 5 mg/day (uptitration to 10 mg/day if no response at 4 or 8 weeks)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Torasemide prolonged release (PR)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Torasemide immediate release (IR)
Number of subjects: 442
Study: 16181001

Group type: EXPERIMENTAL
Intervention: 200 microg budesonide inhaled from a Respimat Soft Mist Inhaler (Respimat SMI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 200 microg budesonide inhaled from a Turbuhaler dry powder inhaler (Turbuhaler DPI) with fast inhaled flow rate
Number of subjects: 14

Group type: COMPARATOR
Intervention: 200 microg budesonide inhaled from a Turbuhaler dry powder inhaler (Turbuhaler DPI) with slow inhaled flow rate
Number of subjects: 14

Group type: COMPARATOR
Intervention: 250 microg beclomethasone dipropionate inhaled from a pressurized metered dose inhaler (Becloforte pMDI)
Number of subjects: 14
Study: 12774138

Group type: EXPERIMENTAL
Intervention: Topical nitroglycerine ointment (NGO) applied 10 minutes prior to heelstick
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo ointment applied 10 minutes prior to heelstick
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Topical nitroglycerine ointment (NGO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 50
Study: 9658746

Group type: EXPERIMENTAL
Intervention: High school baseball players
Number of subjects: 20

Group type: COMPARATOR
Intervention: Students without baseball experience
Number of subjects: 20
Study: 7982419

Group type: EXPERIMENTAL
Intervention: Controlled-release, prostacyclin-sparing aspirin 75 mg daily plus anticoagulation (intravenous heparin followed by warfarin)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Conventional aspirin 75 mg daily plus anticoagulation (intravenous heparin followed by warfarin)
Number of subjects: 144
Study: 3338726

Group type: EXPERIMENTAL
Intervention: Experimental residential treatment program
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard postdischarge care
Number of subjects: 49
Study: 5762643

Group type: EXPERIMENTAL
Intervention: Live attenuated rubella vaccines
Number of subjects: 54
Study: 31991136

Group type: EXPERIMENTAL
Intervention: Valiant Captivia endograft for blunt thoracic aortic injury
Number of subjects: 50
Study: 29133007

Group type: COMPARATOR
Intervention: PFD (Posterior Fossa Decompression)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: PFDD (Posterior Fossa Decompression with Duraplasty)
Number of subjects: 90
Study: 28419368

Group type: EXPERIMENTAL
Intervention: TT-genotype patients (HIV-uninfected)
Number of subjects: 764

Group type: COMPARATOR
Intervention: HIV infection
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Low CSF leukocytes and cytokine concentrations
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: High CSF proinflammatory cytokine concentrations (HIV-uninfected, TT-genotype patients)
Number of subjects: 764
Study: 26603604

Group type: EXPERIMENTAL
Intervention: Positive Health Programme (PHP)
Number of subjects: 17
Study: 23981507

Group type: EXPERIMENTAL
Intervention: Web-based coaching program with education, motivation, exercise guidance, daily SMS reminders, weekly feedback, and active monitoring by general practitioners.
Number of subjects: 186

Group type: COMPARATOR
Intervention: Usual care and advice from practitioners without the web-based coaching program.
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Web-based coaching program
Number of subjects: 186
Study: 21346383

Group type: EXPERIMENTAL
Intervention: Preoperative CRT (45 Gy with chemotherapy)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Postoperative CRT (45‐51 Gy with chemotherapy)
Number of subjects: 295
Study: 18782482

Group type: EXPERIMENTAL
Intervention: High glycaemic index breakfast cereal meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low glycaemic index breakfast cereal meal
Number of subjects: 0
Study: 16597076

Group type: EXPERIMENTAL
Intervention: Beclate 400 microg/d
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Qvar 400 microg/d
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Beclate and Qvar at higher doses
Number of subjects: 15
Study: 12569265

Group type: EXPERIMENTAL
Intervention: HCT (25 mg once daily for 9 days)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: HCT + LOS (50 mg twice daily for 9 days)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 11050587

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.1% gel plus UVB phototherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle gel plus UVB phototherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: UVB phototherapy alone
Number of subjects: 0
Study: 9316508

Group type: EXPERIMENTAL
Intervention: NIR stent implantation
Number of subjects: 255
Study: 8492925

Group type: EXPERIMENTAL
Intervention: Methazolamide
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 3028545

Group type: EXPERIMENTAL
Intervention: Seven eggs a week
Number of subjects: 168

Group type: COMPARATOR
Intervention: Two eggs a week
Number of subjects: 168
Study: 30281025

Group type: EXPERIMENTAL
Intervention: F/TAF
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: E/C/F/TAF
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: R/F/TAF
Number of subjects: 30
Study: 27252432

Group type: EXPERIMENTAL
Intervention: Hylan G-F 20 (6 mL)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Triamcinolone acetonide (1 mL of 40-mg + 5 mL of 1% lidocaine with epinephrine)
Number of subjects: 99
Study: 25708913

Group type: EXPERIMENTAL
Intervention: everolimus targeting 3-8 ng/ml with reduced-exposure cyclosporine (CsA)
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: everolimus targeting 6-12 ng/ml with reduced-exposure cyclosporine (CsA)
Number of subjects: 833

Group type: COMPARATOR
Intervention: mycophenolic acid (MPA) with standard-exposure CsA
Number of subjects: 833
Study: 23739514

Group type: EXPERIMENTAL
Intervention: Levetiracetam (60 mg/kg/day for one year)
Number of subjects: 76
Study: 20687400

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg/day) administered for 8 to 12 weeks before and during ovarian stimulation
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg/day)
Number of subjects: 232

Group type: COMPARATOR
Intervention: No metformin
Number of subjects: 232
Study: 18752932

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg/day
Number of subjects: 409

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409
Study: 16632133

Group type: EXPERIMENTAL
Intervention: Print intervention
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Print-plus-telephone intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Baron-Kenny method
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 52
Study: 12830193

Group type: EXPERIMENTAL
Intervention: Patient information leaflet
Number of subjects: 949
Study: 10376164

Group type: EXPERIMENTAL
Intervention: Clinical interview by a physician
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Familial occurrence of CTTH
Number of subjects: 499

Group type: COMPARATOR
Intervention: Gender of probands
Number of subjects: 499

Group type: COMPARATOR
Intervention: Familial risk of CTTH
Number of subjects: 499
Study: 8656661

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg as monotherapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg plus hydrochlorothiazide (HCTZ 12.5 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ 12.5 mg) alone
Number of subjects: 18
Study: 1801883

Group type: EXPERIMENTAL
Intervention: alpha‐IFN + 5‐Fluorouracil (5‐FU)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5‐Fluorouracil (5‐FU) alone
Number of subjects: 12
Study: 6127964

Group type: EXPERIMENTAL
Intervention: Oral low-dose combination of theophylline (280 mg) and terbutaline (2.5 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High oral dose of terbutaline (5 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhalation of beta 2-adrenostimulant (1.25 mg terbutaline sulphate)
Number of subjects: 8
Study: 31842828

Group type: EXPERIMENTAL
Intervention: High intensity supervision PrAISED intervention
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate intensity supervision PrAISED intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Brief falls prevention assessment and advice (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PrAISED intervention (both high and moderate supervision)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Primary efficacy outcome - Disability Assessment for Dementia (DAD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Secondary outcomes - physical activity, quality of life, mood, cognition, strength, balance, rate of falls, frailty, and carer strain
Number of subjects: 60